Human medicines European public assessment report (EPAR): Sogroya, somapacitan, Date of authorisation: 31/03/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Zometa, zoledronic acid, Date of authorisation: 20/03/2001, Revision: 40, Status: Authorised

European Medicines Agency Write PMS API implementation Guide (zip)

European Medicines Agency Write PMS API implementation Guide

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Cystadrops, mercaptamine, Date of authorisation: 18/01/2017, Revision: 10, Status: Authorised

Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2 - track changes

Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2